Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LIVN
LIVN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LIVN News
VentriPoint Diagnostics Expands Remote Healthcare Services with AI Partnership
4d ago
PRnewswire
VentriPoint Diagnostics Expands Remote Healthcare Services
4d ago
Newsfilter
LivaNova Receives FDA Approval for New Sleep Apnea Device
Mar 19 2026
seekingalpha
LivaNova Receives FDA Approval for New OSA Treatment Device
Mar 19 2026
Newsfilter
LivaNova PLC Reports Strong Q4 2025 Earnings with Strategic Growth Plans
Feb 25 2026
seekingalpha
LivaNova PLC Reports Strong Q4 2025 Earnings with Double-Digit Growth
Feb 25 2026
Yahoo Finance
LivaNova PLC Q4 Earnings Exceed Expectations
Feb 25 2026
seekingalpha
LivaNova Options Trading Analysis
Feb 02 2026
NASDAQ.COM
Tesla, Microsoft, and Meta Earnings Capture Attention
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 29 2026
Yahoo Finance
Tesla, Microsoft, and Meta Report Strong Earnings
Jan 28 2026
Yahoo Finance
Keybanc Begins Coverage of LivaNova (LIVN) with an Overweight Rating
Dec 20 2025
NASDAQ.COM
LivaNova Presents Significant Seizure Reduction with VNS Therapy at AES Annual Meeting
Dec 03 2025
Newsfilter
LivaNova Appoints New Global Head of Commercialization for OSA to Drive Market Growth
Dec 02 2025
Newsfilter
LivaNova's VNS Therapy Reimbursement Increases by 48% Under Medicare
Nov 24 2025
Newsfilter
Show More News
